About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in New York | 57 Studies

Clinical Trials Multiple SclerosisNew York

Multiple Sclerosis Clinical Trials in New York

Find 57 clinical trials for multiple sclerosis near New York, New York. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-57 of 57 trials

UnknownInvestigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive PatientsThe purposes of this study is to identify types of bacteria that reside in the intestine of healthy individuals and compare them to individuals with Multiple Sclerosis (MS).NCT03092544·Latham, New York TerminatedSingle Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDYThe primary purpose of this single center, randomized, open label study in relapsing Multiple Sclerosis (MS) patients on PLEGRIDY (peginterferon beta-1a) is to assess the effect…NCT02665221·New York, New York CompletedEvaluation of the Onset of Action in Highly Active MS (MAGNIFY)The main purpose of the study was to determine the onset of Mavenclad® action by frequent magnetic resonance imaging (MRI) assessment of the combined unique active (CUA) lesions…NCT03364036·Sydney, New South Wales and 53 others

Multiple Sclerosis Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedCognitive Remediation Augmented With Transcranial Direct Current Stimulation (tDCS)The proposed study will test the feasibility and tolerability of transcranial direct current stimulation (tDCS) added to a cognitive remediation program in n=100 adults.NCT03049969·New York, New York

UnknownAnalysis of MS Patients Who Have Had Greater Than 60 Infusions of NatalizumabThe purpose of this study is to explore the safety and efficacy data in clinic patients who have been treated with Natalizumab for more than 60 continuous infusions.NCT04964700·Latham, New York

No longer availableExpanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple SclerosisTo give expanded access to intrathecal autologous MSC-NP treatment to patients with progressive MS who do not meet the inclusion/exclusion criteria of our Phase II stem cell trial.NCT03822858·New York, New York

Active not recruitingA Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540 in participants with Relapsing Forms of Multiple Sclerosis (RMS)…NCT06220201·Birmingham, Alabama and 33 others

UnknownComparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)People with multiple sclerosis (MS) often experience problems with cognitive functioning, which can be debilitating and interfere with their daily functioning.NCT00914758·Berkely, California and 6 others

CompletedPharmacokinetics of DMF and the Effects of DMF on Exploratory BiomarkersThe purpose of this study is to explore whether DMF (Dimethyl Fumarate) or MMF (monomethyl fumarate) its main bioactive metabolite, is capable of entering the central nervous…NCT02683863·Latham, New York

Active not recruitingBiobank For MS And Other Demyelinating DiseasesTo establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM)…NCT00445367·Phoenix, Arizona and 9 others

CompletedA Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)This study will evaluate the efficacy and safety of ocrelizumab in participants with RRMS who have had a suboptimal response to an adequate course of DMT.NCT02637856·Cullman, Alabama and 81 others

CompletedRELAXaHEAD for Headache Patients (Phase I)The goal of this research is to assess the utility of smartphone-based progressive muscle relaxation (PMR) for the treatment of headaches.NCT03183791·New York, New York

CompletedAssessment of tDCS-Induced Neuronal Responses in Multiple Sclerosis (MS) With Advanced MRIThe objective of this trial is to measure the changes in neural activities during tDCS session using Magnetic Resonance Imaging (MRI).NCT03564496·New York, New York

CompletedIntrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple SclerosisThe study is an open-label, phase I clinical trial designed to evaluate the safety and tolerability of intrathecal administration of autologous mesenchymal stem cell-derived…NCT01933802·New York, New York

RecruitingNYSCF Scientific Discovery BiobankThe New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood…NCT06203106·New York, New York

CompletedEffects of Acthar on Recovery From Cognitive Relapses in MSThe purpose of this study is to evaluate the effect of a medication called Acthar on recovery from multiple sclerosis-related relapses that impact cognition.NCT02290444·Buffalo, New York

CompletedPilot Study of Transcranial Direct Current Stimulation (tDCS)This study will test the tolerability and preliminary efficacy of transcranial direct current stimulation (tDCS) combined with a cognitive training program, remotely-delivered…NCT02746705·New York, New York

PreviousPage 3 of 3

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia